BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Puromycin

A cinnamamido ADENOSINE found in STREPTOMYCES alboniger. It inhibits protein synthesis by binding to RNA. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis.

300+ PubMed studies analyzed · Evidence Score: 38.9

Research Domains

Puromycin has been studied across 20 research domains including 🏋️ Muscle & Hypertrophy, 🫘 Kidney, 🔬 Oncology, 🧠 Memory, 🫁 Liver & Detox. The primary research focus is 🏋️ Muscle & Hypertrophy with 21% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Puromycin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cerulenin
5 shared targets
Thapsigargin
7 shared targets
Fluvastatin
4 shared targets
monorden
6 shared targets
KN
5 shared targets
Thioinosine
6 shared targets
Deslanoside
6 shared targets
Itraconazole
6 shared targets
Tetracycline
4 shared targets
Flumethasone
5 shared targets
Loading evidence profile...

This evidence profile for Puromycin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.